comparemela.com
  1. Home
  2. Live Updates
  3. Brian Varnum - Breaking News

Latest Breaking News On - Brian varnum - Page 1 : comparemela.com

Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesPierre kymeJoyce allaireBrian varnumArmata pharmaceuticals incDefense health agencyInnoviva incTechnology enterprise consortiumPrnewswire armata pharmaceuticals incInnoviva strategic opportunitiesUs department of defenseLifesci advisorsWarfighter medical research programRecent developmentsChief executive officerMedical technology enterprise consortium

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allairePierre kymeUs department of defenseLifesci advisorsDefense health agencyArmata pharmaceuticals incWarfighter medical research programInnoviva incInnoviva strategic opportunitiesTechnology enterprise consortiumPrnewswire armata pharmaceuticals incRecent developmentsChief executive officerMedical technology enterprise consortium

Phage cocktail, AP-PA02, may safely treat Pseudomonas aeruginosa infection | Early CF trial reports safety, potential efficacy

The phage therapy was well tolerated and eased Pseudomonas aeruginosa airway load in treated trial patients, Phase 2b CF study proposed.

Brian varnumMina pastagiaArmata pharmaceuticals

Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a SWARM-P a Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesMina pastagiaBrian varnumJoyce allairePierre kymeLifesci advisorsArmata pharmaceuticals incPrnewswire armata pharmaceuticals incNon cystic fibrosis bronchiectasisChief medical officerChief executive officerArmata pharmaceuticalsAnnual reportSci advisors

Form 8-K Armata Pharmaceuticals, For: Nov 16

Form 8-K Armata Pharmaceuticals, For: Nov 16
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarina del reyBrian varnumJules haimovitzOdysseasd kostasJosephm pattiRobinc kramerSarah schlesingerErin butlerToddc petersonArmata pharmaceuticals incErnst youngName of each exchange onSecurities exchangeCommission file numberExchange act
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.